转基因动物乳腺生物反应器相关技术及研究进展

梁振鑫, 尹富强, 刘庆友, 李力

中国生物工程杂志 ›› 2015, Vol. 35 ›› Issue (2) : 92-98.

PDF(442 KB)
PDF(442 KB)
中国生物工程杂志 ›› 2015, Vol. 35 ›› Issue (2) : 92-98. DOI: 10.13523/j.cb.20150214
综述

转基因动物乳腺生物反应器相关技术及研究进展

  • 梁振鑫1, 尹富强1, 刘庆友2, 李力1
作者信息 +

Progress and Technology in Mammary Gland Bioreactor of Transgenic Animals

  • LIANG Zhen-xin1, YIN Fu-qiang1, LIU Qing-you2, LI Li1
Author information +
文章历史 +

摘要

转基因动物乳腺生产人类重组蛋白人血清白蛋白(hSA)、人纤维蛋白原(hFIB)、人蛋白C (hPC)、人凝血因子(hF-Ⅷ) 和(hF-Ⅸ)等具有较高市场潜力,使其在医学领域获得广泛应用。对转基因动物乳腺生物反应器的优势、目的基因选择、载体构建、基因工程技术、重组蛋白在肿瘤治疗上的应用、当前困境和未来前景等方面进行较为全面的综述,以期能有助于转基因动物生物反应器的研究。此外较详细地探讨了利用 CRISPR-Cas基因打靶技术生产高表达量的人类重组蛋白的可能性。

Abstract

Production of human serum albumin (hSA), fibrinogen (hFIB), human protein c (hPC), human blood clotting factor VIII (HF-VIII)and human blood clotting factor (hF-IX) by mammary gland bioreactor of transgenic has great market potential and is widely used in medical areas. A comprehensive review was made on the advantages, selection of target genes, construction of vector, genetic engineering technology, the application of recombinant proteins in cancer treatment, problems and prospects of mammary gland bioreactor of transgenic animals, in order to contribute to the study on transgenic animal bioreactors. Also the possibility of high level expression of human recombinant proteins by the method of CRISPR-Cas gene targeting was discussed.

关键词

动物乳腺生物反应器 / 载体构建 / 转基因技术 / 生物制药

Key words

Mammary gland bioreactor / Vector construction / Transgenic technology / Bio-pharmacy

引用本文

导出引用
梁振鑫, 尹富强, 刘庆友, 李力. 转基因动物乳腺生物反应器相关技术及研究进展[J]. 中国生物工程杂志, 2015, 35(2): 92-98 https://doi.org/10.13523/j.cb.20150214
LIANG Zhen-xin, YIN Fu-qiang, LIU Qing-you, LI Li. Progress and Technology in Mammary Gland Bioreactor of Transgenic Animals[J]. China Biotechnology, 2015, 35(2): 92-98 https://doi.org/10.13523/j.cb.20150214
中图分类号: Q819   

参考文献


[1] Gordon K, Lee E, Vitale J, et al. Production of human plasminogen activactor intransgenic mice milk. Bio Technol, 1987, 5:1183-1187.

[2] Yan H.Cell Engineering.Beijing:Chemical Industry Press,2013.177.

[3] Yanli Wang,Sihai Zhao,Liang Bai,et al. Expression systems and species used for transgenic animal bioreactors.BioMed Research International,2013,3(15):e580463

[4] Liu Y M,Zhang Z Q. Animal mammary gland bioreactor and biological pharmacy. Bulletin of Biology,2009, 44(10):19-20.

[5] Fu Y H, Zhou X M, Qian Q J.The current progress of mammary gland bioreactor for research and industry.China Animal Husbandry & Veterinary Medicine, 2010,37(8):45-51.

[6] Invitrogen. pBC1 Milk expression vector kit.www.invitrogen.com.2010,8.

[7] Shao Z L, Wu X J,Chen H X, et al. A successive three-step gap-repair method to generate the mWAP-hLYZ hybrid gene locus.Letters in Biotechnology,2012,23(5):648-652.

[8] Zheng Y Y,Zhou Y R,Chen H X, et al. A successive three-step gap-repair method to generate the bovine αS1-casein-hLYZ hybrid gene locus.Letters in Biotechnology,2013,24(2):173-177.

[9] Fujiwara Y, Miwa M, Takahashi R I, et al. Position- independent and high- level expression of human α-lactalbumin in the milk of transgenic rats carrying a 210 kb YAC DNA. Mol Reprod Dev,1997, 47:157-163.

[10] Yang P H, Wang J W, Gong G C,et al.Cattle Mammary bioreactor generated by a novel procedure of transgenic cloning for large-scale production of functional human lactoferrin.Plos One,2008,3(10):e3453.

[11] Palpant N J, Dudzinski D,et al.Zinc finger nucleases: looking toward translation. Gene Ther, 2013,20(2):121-127.

[12] Wang Y S, Xu L, Guo W J,et al.Zinc-finger nickase-mediated insertion of the lysostaphin gene into the beta-casein locus in cloned cows.Nature Communications,2013,4:2565.

[13] Thomas G, Charles A G, Carlos F,et al.ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends in Biotechnology, 2013,31(7): 397-405.

[14] Shaida Moghaddassi, Will Eyestone, Colin E Bishop.Talen-mediated modification of the bovine genome for large-scale production of human serum albumin.Plos One,2014,9:89631.

[15] Hagen R, Lennart R,André P,et al. Exploiting CRISPR/Cas: interference mechanisms and applications. International Journal of Molecular Science, 2013, 14:14518-14531.

[16] Yoshimi K, Kaneko T, Voigt B, et al.Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-Cas platform.Nature Communications,2014,7:1-9

[17] Chen Z N, Yang X M, Zheng M,et al.The recombinant chimeric antibody chHAb18 against hepatocellular carcinoma can be produced in milk of transgenic mice.Transgenic Res,2011, 20:321-330.

[18] Yu H Q, Cheng J Q, Liu S G,et al.Large-scale production of functional human lysozyme in transgenic cloned goats.Journal of Biotechnology,2013,68:676- 683.

[19] Krisztián Kvell,Tamás Czömpöly, László Hiripi,et al.Characterisation of eGFP-transgenic BALB/c mouse strain established by lentiviral transgenesis.Transgenic Research, 2010,1:105-112.

[20] Martello G, Smith A.The nature of embryonic stem cells.Annu Rev Cell Dev Biol, 2014,30:647-675.

[21] Stefan Moisyadi,Joseph M Kaminski,Ryuzo Yanagimachi.Use of intracytoplasmic sperm injection (ICSI) to generate transgenic animals.Comp Immunol Microbiol Infect Dis, 2009,32(2): 47-60.

[22] Lu Y D,Zhang X,Jing M A,et al.Establishment of a sleeping beauty transposase expressing transgenic mouse model. Chinese Journal of Comparative Medicine. 2013, 23(10): 7-10.

[23] Veronika Yuskevich, Yuriy Khodarovich, German Kagarliskiy,et al.Expression of humanized anti-Her2/neu single-chain IgG1 like antibody in mammary glands of transgenic mice. Biochimie, 2011,93:628-630.

[24] Daniel L,Joanna Z, Marlena S,et al.Expression of human growth hormone in the milk of transgenic rabbits with transgene mapped to the telomere region of chromosome 7q.J Appl Genetics,2012, 53:435-442.

[25] Guillaume Chevreux, Valegh Faid,Jean-Marc Scohyers,et al.N-/O-glycosylation analysis of human FVIIa produced in the milk of transgenic rabbits.Glycobiology,2013,23 (12):1531-1546.

[26] Geun-Cheol G,William H V,Kevin E V. Analysis of the N-glycans of recombinant human factor IX purified from transgenic pig milk.Glycobiology,2008, 7: 526-539.

[27] Meng-Hwan Lee, Yin-Shen Lin, Ching-Fu Tu,et al.Recombinant human factor IX produced from transgenic porcine milk. BioMed Research International,2014,5(18):e315375.

[28] Jun Liu,Yan Luo,Hengtao Ge,et al. Anti-bacterial activity of recombinant human β-Defensin-3 secreted in the milk of transgenic goats produced by somatic cell nuclear transfer.Plos One,2013,8(6):e65379.

[29] Wright G,Carver A,Cottom D,et al. High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep. Bio Technol, 1991, 9:830-834.

[30] Schnieke A E,Kind A J,Ritchie W A,et al. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts.Science,1997,278:2130-2133.


PDF(442 KB)

2273

Accesses

0

Citation

Detail

段落导航
相关文章

/